Stockreport

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

Serina Therapeutics, Inc.  (SER) 
PDF HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ [Read more]